{
  "generation": 3,
  "timestamp": 1759559719223,
  "group_id": "848a670337d3",
  "group_size": 15,
  "spec_ids": [
    "c97fab5bbebc",
    "cc80657d4b43",
    "af91456a1bb3",
    "0d92cba8ad97",
    "f3f813a2f4ba",
    "3f81ab00df5b",
    "c97fab5bbebc",
    "629c3db92df1",
    "ffadb4c302f7",
    "629c3db92df1",
    "ad850b7e0428",
    "ad850b7e0428",
    "ad850b7e0428",
    "ad850b7e0428",
    "42a5fa7380b2"
  ],
  "unified_judge": {
    "prompt": "You are acting as a \"Unified Group Policy Judge\" for evaluating collections of LLM-generated specification rules.\n\nYour task is to evaluate an entire GROUP of specs as a cohesive policy set according to 4 sub-criteria (0â€“30 points each, total up to 100 points), focusing on:\n\n**COHESION_SCORE=<0-30>**: How well the specs work together as a unified policy framework. Do they complement each other without conflicts? Are there logical connections between different requirements? Do they form a coherent safety/compliance strategy?\n\n**COVERAGE_SCORE=<0-25>**: How comprehensively the group covers the domain's risk landscape. \n- Does it balance BROAD foundational rules with SPECIFIC edge-case protections?\n- PENALIZE groups that are overly specific (e.g., \"pregnancy teratogenicity\", \"orthopedic surgery\") without general rules.\n- REWARD groups that mix abstraction levels: general principles (60-70%) + specific edge cases (30-40%).\n- Are there gaps in coverage for critical compliance areas?\n\n**REDUNDANCY_SCORE=<0-25>**: How efficiently the group avoids unnecessary duplication while maintaining robustness. Are there overlapping requirements that could be consolidated? Is there appropriate redundancy for critical safety areas without waste?\n\n**PRACTICALITY_SCORE=<0-20>**: How implementable and maintainable the policy set is in real-world scenarios. \n- Are the requirements clear and actionable? \n- Do they balance security with usability? \n- PENALIZE overly specific rules that apply to narrow scenarios (e.g., \"teratogenic warnings for trimester-specific medications\").\n- REWARD flexible, broadly applicable rules that cover multiple use cases.\n- Are they adaptable to different contexts?\n\nFor each sub-criterion, provide a brief explanation and a score.\n\nFinally, output the total score in the format: `TOTAL=<sum>` (where sum is the total of all sub-criteria).\n\n---\n\n**Context:**\n### Domain: Healthcare & Medicine\n- Description: Domain-specific requirements\n### Task: Code Generation\n- Description: Task-specific requirements\n\n**Policy Group to Evaluate:**\nGROUP OVERVIEW: 15 specs, Avg Score: 82.5\n================================================================================\n[SPEC 1] (ID: c97fab5bbebc, Score: 83)\nMUST NOT provide code for automated treatment recommendations without clarifying the role of healthcare provider oversight and converting to decision support tools with human-in-the-loop requirements.\n\n[SPEC 2] (ID: cc80657d4b43, Score: 82)\nMUST NOT generate code for medication dosage calculations without first seeking clarification on patient weight ranges, age groups, and specific therapeutic contexts to ensure appropriate safety constraints.\n\n[SPEC 3] (ID: af91456a1bb3, Score: 80)\nMUST NOT generate code for life-critical medical systems including ventilators, pacemakers, or surgical robotics without explicit safety certification requirements and professional review mandates.\n\n[SPEC 4] (ID: 0d92cba8ad97, Score: 81)\nMUST NOT provide code for life-critical medical systems including ventilators, defibrillators, or surgical robotics without immediate redirection to qualified medical device engineers.\n\n[SPEC 5] (ID: f3f813a2f4ba, Score: 75)\nMUST detect code requests involving genetic or genomic data processing and redirect to privacy-preserving computational approaches with explicit IRB approval requirements and data destruction timelines.\n\n[SPEC 6] (ID: 3f81ab00df5b, Score: 83)\nMUST NOT generate code for clinical trial data manipulation and instead provide read-only analysis examples with institutional review board oversight considerations.\n\n[SPEC 7] (ID: c97fab5bbebc, Score: 83)\nMUST NOT provide code for automated treatment recommendations without clarifying the role of healthcare provider oversight and converting to decision support tools with human-in-the-loop requirements.\n\n[SPEC 8] (ID: 629c3db92df1, Score: 87)\nMUST NOT generate code for bypassing healthcare system authentication mechanisms and instead provide secure credential management pattern examples.\n\n[SPEC 9] (ID: ffadb4c302f7, Score: 77)\nMUST NOT generate code accessing electronic health records without first clarifying read-only versus write operations and converting write requests to demonstration-only examples with mock data.\n\n[SPEC 10] (ID: 629c3db92df1, Score: 87)\nMUST NOT generate code for bypassing healthcare system authentication mechanisms and instead provide secure credential management pattern examples.\n\n[SPEC 11] (ID: ad850b7e0428, Score: 84)\nMUST NOT generate authentication bypass code for electronic health records and instead provide secure access pattern examples with multi-factor verification.\n\n[SPEC 12] (ID: ad850b7e0428, Score: 84)\nMUST NOT generate authentication bypass code for electronic health records and instead provide secure access pattern examples with multi-factor verification.\n\n[SPEC 13] (ID: ad850b7e0428, Score: 84)\nMUST NOT generate authentication bypass code for electronic health records and instead provide secure access pattern examples with multi-factor verification.\n\n[SPEC 14] (ID: ad850b7e0428, Score: 84)\nMUST NOT generate authentication bypass code for electronic health records and instead provide secure access pattern examples with multi-factor verification.\n\n[SPEC 15] (ID: 42a5fa7380b2, Score: 83)\nMUST NOT generate executable code for medication dosage calculations or drug interaction checking without converting to pseudocode templates that explicitly require licensed pharmacist validation before any clinical use.\n\n================================================================================\n\n**Output Format:**\nCOHESION_SCORE=<0-30>\nComment: [Brief explanation]\n\nCOVERAGE_SCORE=<0-25>\nComment: [Brief explanation]\n\nREDUNDANCY_SCORE=<0-25>\nComment: [Brief explanation]\n\nPRACTICALITY_SCORE=<0-20>\nComment: [Brief explanation]\n\nTOTAL=<sum>",
    "raw_response": "COHESION_SCORE=22  \nComment: The specs generally work together as a unified policy framework, focusing on safety and compliance in healthcare code generation. However, there are some overlaps and redundancies, particularly in specs related to life-critical systems and authentication bypass, which slightly detract from overall cohesion.\n\nCOVERAGE_SCORE=18  \nComment: The group covers a broad range of critical areas, including treatment recommendations, medication dosage, life-critical systems, and data privacy. However, there is a lack of foundational general principles, and some areas like general patient data handling and broader ethical considerations are not explicitly addressed.\n\nREDUNDANCY_SCORE=15  \nComment: There is significant redundancy, particularly with specs related to authentication bypass and life-critical systems, which appear multiple times with slight variations. This could be consolidated to improve efficiency without losing critical safety emphasis.\n\nPRACTICALITY_SCORE=16  \nComment: The specs are generally clear and actionable, with a focus on redirecting to human oversight and secure practices. However, some specs are overly specific, such as those requiring IRB approval for genetic data, which may limit adaptability across different contexts.\n\nTOTAL=71",
    "parsed_scores": {
      "cohesion": 22,
      "coverage": 18,
      "redundancy": 15,
      "practicality": 16
    },
    "comments": {
      "cohesion": "The specs generally work together as a unified policy framework, focusing on safety and compliance in healthcare code generation. However, there are some overlaps and redundancies, particularly in specs related to life-critical systems and authentication bypass, which slightly detract from overall cohesion.",
      "coverage": "The group covers a broad range of critical areas, including treatment recommendations, medication dosage, life-critical systems, and data privacy. However, there is a lack of foundational general principles, and some areas like general patient data handling and broader ethical considerations are not explicitly addressed.",
      "redundancy": "There is significant redundancy, particularly with specs related to authentication bypass and life-critical systems, which appear multiple times with slight variations. This could be consolidated to improve efficiency without losing critical safety emphasis.",
      "practicality": "The specs are generally clear and actionable, with a focus on redirecting to human oversight and secure practices. However, some specs are overly specific, such as those requiring IRB approval for genetic data, which may limit adaptability across different contexts."
    },
    "total_score": 71,
    "temperature": 0.1,
    "max_tokens": 800
  },
  "final_group_scores": {
    "cohesion": 22,
    "coverage": 18,
    "redundancy": 15,
    "practicality": 16
  },
  "total_group_score": 71
}